Injectable Therapies in Diabetes

Similar documents
Injectable Therapies in Diabetes

Injectable Therapies in Diabetes

Information for Patients

Initiating Injectables in Type 2 Diabetes. Tara Kadis Team Leader Diabetes Nurse Specialist York Teaching Hospital

The principles of insulin adjustment guidance

How they work and when to take them. Diabetes Medications

KEEPING SAFE WITH INSULIN THERAPY

What the Pill Looks Like. How it Works. Slows carbohydrate absorption. Reduces amount of sugar made by the liver. Increases release of insulin

Insulin Management. By Susan Henry Diabetes Specialist Nurse

There have been important changes in diabetes care which may not be covered in undergraduate textbooks.

TREATMENTS FOR TYPE 2 DIABETES. Susan Henry Diabetes Specialist Nurse

Short-acting insulins. Biphasic insulins. Intermediate- and long-acting insulins

TYPE 2 DIABETES CRITERIA FOR REFERRAL TO LEVEL 2 OOHS

INJECTABLE THERAPY FOR THE TREATMENT OF DIABETES

End of Life Diabetes Care

Fasted and Consented but Blood Glucose 18mmol/L or How to Manage Diabetes in the Peri-Operative Period

Managing diabetes if you are having a colonoscopy

GLP-1 Receptor Agonists and SGLT-2 Inhibitors. Debbie Hicks

Diabetes, Type 2 Management

Drugs used in Diabetes. Dr Andrew Smith

Objectives. How Medicine Works to Control Blood Sugar Levels. What Happens When We Eat? What is diabetes? High Blood Glucose (Hyperglycemia)

GLP-1 receptor agonists for type 2 diabetes currently available in the U.S.

Peri-operative management of the surgical patient with diabetes GL059

INJECTABLE THERAPIES IN DIABETES. Barbara Ann McKee Diabetes Specialist Nurse

BEST 4 Diabetes. Optimisation of insulin module

EFFECTIVE SHARE CARE AGREEMENT. FOR THE off license use of GLP1 mimetics in combination with insulin IN DUDLEY

Oxford Kidney Unit. Preparing for your operation: information for people with chronic kidney disease

How can we improve outcomes in Type 2 diabetes?

Ertugliflozin (Steglatro ) 5 mg daily. May increase to 15 mg daily. Take in the morning +/- food. < 60: Do not initiate; discontinue therapy

GLP-1 agonists. Ian Gallen Consultant Community Diabetologist Royal Berkshire Hospital Reading UK

FARXIGA (dapagliflozin) Jardiance (empagliflozin) tablets. Synjardy (empagliflozin and metformin hydrochloride) tablets. GLUCOPHAGE* (metformin)

A patient guide to the use of insulin for diabetes

BEST 4 Diabetes. Optimisation of insulin module

Clinical Guidelines. Management of adult patients with diabetes undergoing endoscopic procedures

THIS IS A PATIENT HAND HELD DOCUMENT CARE PATHWAY FOR MANAGEMENT OF INITIATION OF INSULIN

Title Peri-operative Guidelines for the Management of Patients with Diabetes. Author s job title Diabetes Specialist Nurse Department.

Updated August /08/2020

Dept of Diabetes Main Desk

What do you need to know before you go home?

Hypoglyceamia and Exercise

Leicestershire Diabetes Guidelines: Insulin Therapy

Insulin Safety. Tracey Roe DSN SSOT partnership trust

Peri-Operative Guidelines for Management of Diabetes Patients

Starting Insulin in General Practice

DIABETES INDICATIONS FOR INSULIN

STEP THERAPY CRITERIA

BEDFORDSHIRE AND LUTON JOINT PRESCRIBING COMMITTEE (JPC)

Incredible Incretins Abby Frye, PharmD, BCACP

PERIOPERATIVE DIABETES GUIDELINE

Insulin Initiation and Intensification. Disclosure. Objectives

Pump Failure Guidelines

Managing Diabetes when you are having a colonoscopy

Diabetes, Ketone testing in Type 1 Diabetes

Tips and Tricks for Starting and Adjusting Insulin. MC MacSween The Moncton Hospital

TABLE 1A : Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

University Hospitals of Leicester NHS Trust. Carbohydrates. A guide to carbohydrate containing foods for people with diabetes

Managing Hyperglycaemia in Acute (Adult) Inpatients Requiring Enteral Feeding Guidelines

The main symptoms come on over a period of weeks and are:

Insulin Therapies: An Educational Toolkit

DIABETES. Mary Bruskewitz APNP, MS, BC-ADM Clinical Nurse Specialist Diabetes. November 2013

DR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS

GLP-1 RECEPTOR AGONIST SHOULD I TRY IT? VERONICA BRADY, PHD, BC-ADM, CDE PROJECT ECHO JUNE 21, 2018

Types of insulin. Your blood glucose levels. Types of insulin

Case Study: Competitive exercise

Adjusting Your Diabetes Medicine and Diet for a Test or Procedure

GLP-1 (glucagon-like peptide-1) Agonists (Byetta, Bydureon, Tanzeum, Trulicity, Victoza ) Step Therapy and Quantity Limit Criteria Program Summary

STEP 3: Add or Substitute with one of

This program applies to Commercial, GenPlus and Health Insurance Marketplace formularies.

Glucose Control drug treatments

Management of Women with Type I Diabetes or Insulin Treated Type II Diabetes

SCHOOL HEALTH PLAN: DIABETES

Northumbria Healthcare NHS Foundation Trust. Sick Day Rules for People with Diabetes. Issued by the Diabetes Service

Arrange 3 Monthly Review Re-enforce LIFESTYLE advice and check DRUG COMPLIANCE at each visit Target HbA1c < 53mmol/mol

Management of Type 2 Diabetes

Diabetes Newly Diagnosed with NO evidence of DKA

INSULIN 101: When, How and What

TABLE 1A: Formulary Coverage of Insulin Therapies & Indications for Use in Various Populations

Medical care of diabetes - what s new?

Self-Monitoring Blood Glucose (SMBG) Frequency & Pattern Tool

The Wheel of Life Exercise. What s Happening? Where to start the beginning. What's in a meter- are they all the same?

The New Age of Insulin: Exploring the Latest Trends in Insulin Therapy. The New Age of Insulin: Exploring the Latest Trends in Insulin Therapy

A Fact Sheet for Parents and Carers Insulin and Diabetes

Diabetes Medical Management Plan

Management of Adults with Diabetes Undergoing Surgery and Elective Procedures Guidelines. Diabetes Inpatient Steering Group June 2016

Beyond A1C. Non-glycemic Effects of GLP-1 Receptor Agonists. Olga Astapova MD, PhD Luis Chavez MD URMC Endocrinology Fellows

Managing Special Circumstances Key Points

Newer Insulins. Boca Raton Regional Hospital 15th Annual Internal Medicine Conference

Let s not sugarcoat it! Update on Pharmacologic Management of Type II DM

Pharmacological Glycaemic Control in Type 2 Diabetes

GLUCAGON LIKE PEPTIDE (GLP) 1 AGONISTS FOR THE TREATMENT OF TYPE 2 DIABETES, WEIGHT CONTROL AND CARDIOVASCULAR PROTECTION.

Procedure for the prescribing and administration of insulin

Staying safe on an insulin pump

RDNS. Injection Therapy in injection therapy in diabetes. Type 2 Diabetes

Clinical Support Guide Injectable treatments for adults with diabetes

667FM.5.1 MANAGEMENT OF TYPE 2 DIABETES: BLOOD-GLUCOSE-LOWERING THERAPY

Diabetes Medical Management Plan

3. Cardiovascular Disease?

The first stop for professional medicines advice

Diabetes Medical Management Plan

What s New in Type 2 Diabetes? 2018 Diabetes Updates

Transcription:

Injectable Therapies in Diabetes Diabetes Specialist Nurse Linda Burns

Learning Outcomes Understand the place of injectible therapies in diabetes Understand when patients may require insulin therapy Consider insulin profiles and regimes Understand when patients may require GLP1 inhibitors Safe practice and injectible therapies in diabetes

When injectibles therapies are used in diabetes? Type 1 diabetes 1 st line no alternative to insulin lack of insulin leads to burning of body fats and ketone production >?DKA Type 2 diabetes - insulin resistance loss of insulin effectiveness poor response to oral agents. Injectibles then required- Variable time line. May require insulin or Glucagon Like Peptides 1receptors agonists (GLP-1s) by injection

Daily Requirements Normal Daily Insulin Profiles Breakfast Lunch Evening Meal Blood sugar Mealtime insulin Background insulin required for basal metabolic requirements For regular eating pattern you require a background of insulin and three bolus doses of insulin. This happens in health with no diabetes.

Common insulin regimes for Match insulin profile to the needs of individual patients and follow GGC guidelines Once daily intermediate or long acting background insulins eg. Humulin I, Insulatard, Insuman basal, Levemir, Lantus May be used in combination with oral hypoglycaemic agents Twice daily mixed insulin e.g. HumulinI, Novomix 30, Insuman Comb 50 may be used - if not achieving adequate glycaemic control on once daily regime

Common Insulin regimes cont. Three times daily mixed insulin eg. Humalog Mix 50, Insuman Comb 50 If patient is highly insulin resistant Multiple dose injections /basal bolus eg. Lantus or Levemir plus Novorapid or Humalog Insulin Pumps Constant infusion of rapid acting insulin

Types of insulin: short acting (clear) rapid acting (clear). intermediate (cloudy). Fixed (bi phasic) mixtures - combination of short and medium insulin (cloudy) e.g Longer acting insulin analogues (clear) e.g.. New insulins 300iu strength Types of Insulin?

Insulin Patients with T2DM who have concurrent problems, may require insulin urgently for example... Steroid therapy Acute infection Pre or post surgery Gestational diabetes Type 2 diabetes in pregnancy

Insulin therapy getting it right... Injection technique / timing /compliance Carbohydrates Avoiding and treating hypos appropriately Self managing where possible morning insulin lunch / tea time results evening insulin supper / breakfast results Stable blood sugars improved outcomes

Getting it wrong... Delivery devices Withdrawing insulin from pen devices Sharps disposal Insulin prescriptions Communication pathways Patients fasting

Injectable Therapies - GLP1 GLP-1 - Incretin gut hormone Used only in Type 2 diabetes 3 rd line medication although can be used earlier in treatment algorithm Useful if insulin needs to be avoided eg taxi drivers, HGV drivers

GLP1 how do they work? Increases insulin production when blood glucose levels are high. Reduces insulin production when blood glucose levels are low...results in No hypos unless on another agent for example gliclazide Slows down speed of stomach emptying reduce appetite *****weight loss*****

GLP1 currently in use exenatide (Byetta) twice daily injection exenatide (Bydureon) once weekly injection lixisenatide (Lyxumia) Once daily injection. liraglutide (Victoza) once daily injection dulaglutide (Trulicity) Once weekly injections Degludec/liraglutide (Xultophy) once daily insulin/glp1 mixture

side effects of GLP1 Nausea and GI upset can occur on initiation of treatment but usually settles Rare side effect of pancreatits Reduction of appetite Weight loss

Injection technique for insulin and GLP1 agents DSN support initially towards patient self managing Use of Injection prompt sheets Expel 2units prior to injection Why? Size 4 or 5mm needles now - no need to pinch 90 degree angle Rotate sites / Why? Encourage patients not to resheath or -reuse needles

Good injection techniques If DN dependent syringe/needle if available in vial form, to minimise risk of needlestick injuries. If required to use a pen device encourage patient to remove needle, or use a BD safe clip Observe GGC policy Administration of Insulin by Injection and Blood Glucose Monitoring, District Nursing

Further Learning 5 Modules available on Learn Pro Contact diabetes team if any concerns or need advice

Any Questions??? Thank you

Thank you